Genetic Overlap between Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume Indicates Shared Molecular Genetic Mechanisms

Schizophrenia Bulletin

Volumn 44, Issue 4, 2018, Pages 854-864

  Smeland, Olav B ^a,b   Wang, Yunpeng ^a,c,d   Frei, Oleksandr ^a   Li, Wen ^a   Hibar, Derrek P ^e   Franke, Barbara ^f,g   Bettella, Francesco ^a   Witoelar, Aree ^a   Djurovic, Srdjan ^h,i   Chen, Chi Hua ^c,d   Thompson, Paul M ^e   Dale, Anders M ^b,c,d,j   Andreassen, Ole A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g RADBOUD UNIVERSITY   (Netherlands)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ UNIVERSITY OF BERGEN   (Norway)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

common genetic variants; conditional false discovery rate; genome wide association study; pleiotropy; subcortical brain structures

Indexed keywords

DCC PROTEIN; DLG2 PROTEIN; FTCDNL1 PROTEIN; ITIH4 PROTEIN; MESSENGER RNA; PROTEIN; SLC4A10 PROTEIN; SPATS2L PROTEIN; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ARTICLE; BRAIN REGION; BRAIN SIZE; CLINICAL ASSESSMENT; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INTRACRANIAL VOLUME; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PUTAMEN; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; BRAIN; GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PLEIOTROPY; PROCEDURES;

BRAIN; GENETIC LOCI; GENETIC PLEIOTROPY; GENOME-WIDE ASSOCIATION STUDY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; PUTAMEN; SCHIZOPHRENIA;

EID: 85034565370     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbx148     Document Type: Article

References (61)

1. Van Erp TG, Hibar DP, Rasmussen JM, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. Apr 2016;21(4):547-553.
2. Okada N, Fukunaga M, Yamashita F, et al. Abnormal asymmetries in subcortical brain volume in schizophrenia. Mol Psychiatry. Oct 2016;21(10):1460-1466.
3. Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39:1129-1138.
4. Lichtenstein P, Yip BH, Bjork C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234-239.
5. Hibar DP, Stein JL, Renteria ME, et al. Common genetic variants influence human subcortical brain structures. Nature. Apr 09 2015;520(7546):224-229.
6. Moran ME, Hulshoff Pol H, Gogtay N. A family affair: brain abnormalities in siblings of patients with schizophrenia. Brain. 2013;136:3215-3226.
7. Boos HB, Aleman A, Cahn W, Hulshoff Pol H, Kahn RS. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry. 2007;64:297-304.
8. Adolphs R. Neural systems for recognizing emotion. Curr Opin Neurobiol. 2002;12:169-177.
9. Leisman G, Braun-Benjamin O, Melillo R. Cognitive-motor interactions of the basal ganglia in development. Front Syst Neurosci. 2014;8:16.
10. Poldrack RA, Clark J, Pare-Blagoev EJ, et al. Interactive memory systems in the human brain. Nature. 2001;414:546-550.
11. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin rewardseeking behaviour in humans. Nature. 2006;442:1042-1045.
12. Hartberg CB, Sundet K, Rimol LM, et al. Subcortical brain volumes relate to neurocognition in schizophrenia and bipolar disorder and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1122-1130.
13. Kubota M, Van Haren NE, Haijma SV, et al. Association of IQ changes and progressive brain changes in patients with schizophrenia. JAMA Psychiatry. 2015;72:803-812.
14. Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63:182-217.
15. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128-137.
16. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophreniaassociated genetic loci. Nature. 2014;511:421-427.
17. Stein JL, Medland SE, Vasquez AA, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012;44:552-561.
18. Bis JC, DeCarli C, Smith AV, et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet. 2012;44:545-551.
19. Melville SA, Buros J, Parrado AR, et al.; Alzheimer's Disease Neuroimaging Initiative. Multiple loci influencing hippocampal degeneration identified by genome scan. Ann Neurol. 2012;72:65-75.
20. Hibar DP, Adams HH, Jahanshad N, et al. Novel genetic loci associated with hippocampal volume. Nat Commun. 2017;8:13624.
21. Ikram MA, Fornage M, Smith AV, et al. Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet. 2012;44:539-544.
22. Adams HH, Hibar DP, Chouraki V, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci. Dec 2016;19(12):1569-1582.
23. Liu JZ, Hov JR, Folseraas T, et al.; UK-PSCSC Consortium; International PSC Study Group; International IBD Genetics Consortium. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet. 2013;45:670-675.
24. Schork AJ, Wang Y, Thompson WK, Dale AM, Andreassen OA. New statistical approaches exploit the polygenic architecture of schizophrenia-implications for the underlying neurobiology. Curr Opin Neurobiol. 2016;36:89-98.
25. Andreassen OA, Thompson WK, Dale AM. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophr Bull. 2014;40:13-17.
26. Andreassen OA, Thompson WK, Schork AJ, et al.; Psychiatric Genomics Consortium (PGC); Bipolar Disorder and Schizophrenia Working Groups. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013;9:e1003455.
27. Andreassen OA, Harbo HF, Wang Y, et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune related gene loci. Mol Psychiatry. Feb 2015;20(2):207-214.
28. Andreassen OA, Djurovic S, Thompson WK, et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet. 2013;92:197-209.
29. Smeland OB, Wang Y, Lo MT, et al. Identification of genetic loci shared between schizophrenia and the big five personality traits. Sci Rep. 2017;7:2222.
30. Smeland OB, Frei O, Kauppi K, et al. Identification of genetic loci jointly influencing schizophrenia risk and the cognitive traits of verbal-numerical reasoning, reaction time, and general cognitive function. JAMA Psychiatry. July 26 2017. doi:10.1001/jamapsychiatry.2017.1986
31. Desikan RS, Schork AJ, Wang Y, et al. Polygenic overlap between c-reactive protein, plasma lipids and alzheimer's disease. Circulation. Jun 09 2015;131(23):2061-2069.
32. Le Hellard S, Wang Y, Witoelar A, et al.; Schizophrenia Working Group of the Psychiatric Genomics Consortium. Identification of gene loci that overlap between schizophrenia and educational attainment. Schizophr Bull. 2017;43:654-664.
33. Franke B, Stein JL, Ripke S, et al.; Schizophrenia Working Group of the Psychiatric Genomics Consortium; ENIGMA Consortium. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci. 2016;19:420-431.
34. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
35. Bulik-SulliVan BK, Loh PR, Finucane HK, et al.; Schizophrenia Working Group of the Psychiatric Genomics Consortium. LD Score regression distinguishes confounding from polygenicity in genome-wide association stuDies. Nat Genet. 2015;47:291-295.
36. Andreassen OA, Desikan RS, Wang Y, et al. Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms. PLoS One. 2015;10:e0123057.
37. Schork AJ, Thompson WK, Pham P, et al. All SNPs are not created equal: genome-wide association stuDies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet. 2013;9:e1003449.
38. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289-300.
39. Schwartzman A, Lin X. The effect of correlation in false discovery rate estimation. Biometrika. 2011;98:199-214.
40. Nichols T, Brett M, Andersson J, Wager T, Poline JB. Valid conjunction inference with the minimum statistic. Neuroimage. 2005;25:653-660.
41. Kang HJ, Kawasawa YI, Cheng F, et al. Spatio-temporal transcriptome of the human brain. Nature. 2011;478:483-489.
42. GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580-585.
43. Ramasamy A, Trabzuni D, Guelfi S, et al.; UK Brain Expression Consortium; North American Brain Expression Consortium. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014;17:1418-1428.
44. Courchesne E, Chisum HJ, Townsend J, et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology. 2000;216:672-682.
45. Broer L, Buchman AS, Deelen J, et al. GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. J Gerontol A Biol Sci Med Sci. 2015;70:110-118.
46. Sniekers S, Stringer S, Watanabe K, et al. Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence. Nat Genet. Jul 2017;49(7):1107-1112.
47. Eijkelenboom A, Burgering BM. FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol. 2013;14:83-97.
48. Renault VM, Rafalski VA, Morgan AA, et al. FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell. 2009;5:527-539.
49. Schmidt-Strassburger U, Schips TG, Maier HJ, et al. Expression of constitutively active FoxO3 in murine forebrain leads to a loss of neural progenitors. FASEB J. 2012;26:4990-5001.
50. Li Z, Xiang Y, Chen J, et al. Loci with genome-wide associations with schizophrenia in the Han Chinese population. Br J Psychiatry. 2015;207:490-494.
51. Song J, Patel M, Rosenzweig CN, et al. Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay. Clin Chem. 2006;52:1045-1053.
52. Ohi K, Shimada T, Nitta Y, et al. Schizophrenia risk variants in ITIH4 and CALN1 regulate gene expression in the dorsolateral prefrontal cortex. Psychiatr Genet. 2016;26:142-143.
53. Jacobs S, Ruusuvuori E, Sipila ST, et al. Mice with targeted Slc4a10 gene disruption have small brain ventricles and show reduced neuronal excitability. Proc Natl Acad Sci U S A. 2008;105:311-316.
54. Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3:153-165.
55. Van Den Heuvel DM, Pasterkamp RJ. Getting connected in the dopamine system. Prog Neurobiol. 2008;85:75-93.
56. Manitt C, Mimee A, Eng C, et al. The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J Neurosci. 2011;31:8381-8394.
57. Kahn RS, Sommer IE, Murray RM, et al. Schizophrenia. Nat Rev Dis Primers. 2015;1:15067.
58. Grant A, Fathalli F, Rouleau G, Joober R, Flores C. Association between schizophrenia and genetic variation in DCC: a case-control study. Schizophr Res. 2012;137:26-31.
59. Kirov G, Pocklington AJ, Holmans P, et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signaling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2012;17:142-153.
60. Nithianantharajah J, Komiyama NH, McKechanie A, et al. Synaptic scaffold evolution generated components of vertebrate cognitive complexity. Nat Neurosci. 2013;16:16-24.
61. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet. 2013;14:483-495.